This is a promotional website intended for UK healthcare professionals only.

Apraclonidine 1% w/v Eye Drops, Solution (apraclonidine hydrochloride) Prescribing Information can be found here. Adverse Event Reporting Information can be found at the end of this page.

The role of IOPIDINE® in clinical practice

Marketed as both Iopidine 1% w/v and Apraclonidine 1% w/v in the UK

Listen as Prof. Philippe Denis, MD, PhD, FEBO, the Head of the University Hospital of Lyon, France, and the Vice President of the French Glaucoma Society discuss the role of IOPIDINE® in his current clinical practice.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Essential Pharma on +44 (0)1423 850700 or at MedicalInformation-UK@essentialpharmagroup.com.

Your message was successfully sent. We will be in touch soon.

There was a problem trying to send your message. Please try again.